Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3

Journal of Cell Biology

Volumn 149, Issue 6, 2000, Pages 1309-1323

  Hotary, Kevin ^a   Allen, Edward ^a   Punturieri, Antonello ^a   Yana, Ikuo ^a   Weiss, Stephen J ^a  

^a UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Collagen; Metalloproteinases; Mock; Scatter factor hepatocyte growth factor; Tubulogenesis

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; COLLAGENASE 3; GELATINASE A; GELATINASE B; MATRILYSIN; MEMBRANE METALLOENDOPEPTIDASE; SCATTER FACTOR; STROMELYSIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL STRAIN; CELL STRAIN COS1; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME BINDING; INTERSTITIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DIVISION; CELL LINE; CELL MOVEMENT; COLLAGEN; COS CELLS; DOGS; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; HEPATOCYTE GROWTH FACTOR; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICROSCOPY, ELECTRON; PHENYLALANINE; PROTEASE INHIBITORS; THIOPHENES; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFECTION;

ANIMALIA;

EID: 0034641107     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.149.6.1309     Document Type: Article

References (67)

1. Aimes, R.T., and J.P. Quigley. 1995. Matrix metalloproteinase-2 is an interstitial collagenase. J. Biol. Chem. 270:5872-5876.
2. Belien, A.T.J., P.A. Paganetti, and M.E. Schwab. 1999. Membrane-type 1 matrix metalloproteinase (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J. Cell Biol. 144:373-384.
3. Benbow, U., M.P. Schoenermark, T.I. Mitchell, J.L. Rutter, K. Shimokawa, H. Nagase, and C.E. Brinckerhoff. 1999. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type 1 collagen. J. Biol. Chem. 274:25371-25378.
4. Birchmeier, C., and W. Birchmeier. 1993. Molecular aspects of mesenchymalepithelial interactions. Annu. Rev. Cell Biol. 9:511-540.
5. Birkedal-Hansen, H. 1987. Catabolism and turnover of collagens: collagenases. Meth. Enzymol. 144:140-167.
6. Brooks, P.C., S. Stromblad, L.C. Sanders, T.L. von Schalscha, R.T. Aimes, W.G. Steller-Stevenson. J.P. Quigley, and D.A. Cheresh. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell. 85:683-693.
7. D'Armiento, J., T. Dicolandrea, S.S. Dalal, Y. Okada, M.-T. Huang, A.H. Conney, and K. Chada. 1995. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell. Biol. 15:5732-5739.
8. D'Ortho, M.-P., H. Will, S. Atkinson, G. Butler, A. Messent, J. Gavrilovic, B. Smith, R Timpl, L. Zardi, and G. Murphy. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250:751-757.
9. Dunsmore, S.E., U.K. Saarialho-kere. J.D. Roby, C.L. Wilson, L.M. Matrisian, H.G. Welgut, and W.C. Parks. 1998. Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102:1321-1331.
10. Elsdale, T., and J. Bard. 1972. Collagen substrata for studies on cell behavior. J. Cell Biol. 54:626-637.
11. Fukuda, Y., Y. Masuda, J.-I. Kishi, Y. Hashimoto, T. Hayakawa, H. Nogawa, and Y. Nakanishi. 1988. The role of interstitial collagens in cleft formation of mouse embryonic submandibulat gland during initial branching. Development, 103:259-267.
12. Gumbiner, B.M. 1992. Epithelial morphogenesis. Cell. 69:385-387.
13. Hiraoka, N., E. Allen, I.J. Apel, M.R. Gyetko, and S.J. Weiss. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:365-377.
14. Holmbeck, K., P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov, M. Mankani, P.G. Robey, A.R. Poole, I. Pidoux, et al. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:81-92.
15. Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1048-1051.
16. Kadono, Y., K. Shibahara, M. Namiki, Y. Watanabe, M. Seiki, and H. Sato. 1998. Membrane-type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in Madin-Darby canine kidney epithelial cells. Biochem. Biophys. Res. Comm. 251:681-687.
17. Knauper, V., H. Will, C. Lopez-Otin, B. Smith, S.J. Atkinson, H. Stanton, R.M. Hembry, and G. Murphy. 1996. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem. 271:17124-17131.
18. Koshikawa, N., G. Giannelli, V. Cirulli, K. Miyazaki, and V. Quaranta. 2000. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148:615-624.
19. Lehti, K., J. Lohi, H. Valtanen, and J. Keski-Oja. 1998. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J. 334:345-353.
20. Lelongt, B., G. Trugnan, G. Murphy, and P.M. Ronco. 1997 Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis, but only MMP9 is required for renal organogenesis in vitro. J. Cell Biol. 136:1363-1373.
21. Liu, X., H. Wu, M. Byrne, J. Jeffrey, S. Krane, and R. Jaenisch. 1995. A targeted mutation al the known collagenase cleavage site in mouse type 1 collagen impairs tissue remodeling. J. Cell Biol. 130:227-237.
22. Liu, Z., J.M. Shipley, T.H. Vu, X. Zhou, L.A. Diaz, Z. Werb, and R.M. Senior. 1998. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188:475-482.
23. Llano, E., A.M. Pendas, J.P. Freije, A. Nakano, V. Knauper, G. Murphy, and C. Lopez-Otin. 1999. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase A overexpressed in brain tumors. Cancer Res. 59:2570-2576.
24. Lochter, A., A. Srebrow, C.J. Sympson, N. Terracio, Z. Werb, and M.J. Bissell. 1997a. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272:5007-5015.
25. Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell. 1997b. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139: 1861-1872.
26. Mason, D.P., R.D. Kenagy, D. Hasenstab, D.F. Bowen-Pope, R.A. Siefert, S. Coats, S.M. Hawkins, and A.W. Clowes. 1999. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ. Res. 85:1179-1185.
27. Masson, R., O. Lefebvre, A. Noel, M. El Fahime, M.-P. Chenard, C. Wendling, F. Kebers, M. LeMeur, A. Dierich, J.-M. Foidart, et al. 1998. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J. Cell Biol. 140:1535-1541.
28. Montesano, R., G. Schaller, and L. Orci. 1991a. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell. 66:697-711.
29. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991b. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:901-908.
30. Montesano, R., J.V. Soriano, G. Hosseini, M.S. Pepper, and H. Schramek. 1999. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darhy canine kidney epithelial cells. Cell Growth Diff. 10:317-332.
31. Mudgett, J.S., N.I. Hutchinson, N.A. Chartrain, A.J. Forsyth, J. McDonnell, I.I. Singer, E.K. Bayne, J. Flanagan, D. Kawka, C.F. Shen, et al. 1998. Susceptibility of stromelysin-1 deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum. 41:110-121.
32. Murphy, G., and J. Gavrilovic. 1999. Proteolysis and cell migration: creating a path? Curr. Opin. Cell Biol. 11:614-621.
33. Nagase, H., and J.F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491-21494.
34. Nakada, M., H. Nakamura, E. Ideda, N. Fujimoto, J. Yamashita, H. Sato, M. Seiki, and Y. Okada. 1999. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Am. J. Pathol. 154:417-428.
35. Nakahara, H., L. Howard, E.W. Thompson, H. Sato, M. Seiki, Y. Yeh, and W.-T. Chen. 1997. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA. 94:7959-7964.
36. Ohuchi, E., K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272:2446-2451.
37. Olson, M.W., M. Toth, D.C. Gervasi, Y. Sado, Y. Ninomiya, and R. Fridman. 1998. High affinity binding of latent matrix metalloproteinase-9 to the a2(IV) chain of collagen IV. J. Biol. Chem. 273:10672-10681.
38. Ota, K., W.G. Stetler-Stevenson, O. Yang, A. Kumar, J. Wada, N. Kashihara, E.I. Wallner, and Y.S. Kanway. 1998. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor. Kidney Int. 54:131-142.
39. Parsons, D.F., M. Marko, and K. Wansor. 1983. Elastic reticulum and collagen of normal mouse peritoneum: a conventional and high-voltage electron microscopy study. Micron. 14:1-10.
40. Pei, D. 1999a. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J. Biol. Chem. 274:8925-8932.
41. Pei, D. 1999b. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage. Cell Research. 9:291-303.
42. Pei, D., and S.J. Weiss. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 375:244-247.
43. Pei, D.Q., and S.J. Weiss. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271:9135-9140.
44. Pei, D.Q., G. Majmudar, and S.J. Weiss. 1994. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269:25849-25855.
45. Polette, M., and P. Birembaut. 1998. Membrane-type metalloproteinases in tumor invasion. Int. J. Biochem. Cell Biol. 30:1195-1202.
46. Pulcher, B.K., J.A. Dumin, B.D. Sudbeck, S.M. Krane, H.G. Welgus, and W.C. Parks. 1997. The activity of collagenase-1 is required for keratinocyte migration on a type 1 collagen matrix. J. Cell Biol. 137:1445-1457.
47. Rosenthal, E.L., T.M. Johnson, E.D. Allen, I.J. Apel, A. Punturieri, and S.J. Weiss. 1998. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res. 58:521-530.
48. Rudolph-Owen, L.A., P. Cannon, and L.M. Matrisian. 1998. Overexpression of the matrix metalloproteinase matrilysin results in premature mammary gland differentiation and male infertility. Mol. Biol. Cell. 9:421-435.
49. Santavicca, M., A. Noel, H. Angliker, I. Stoll, J.-P. Segain, P. Anglard, M. Chretien, N. Seidah, and P. Basset. 1996. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochem. J. 315: 953-958.
50. Sato, H., T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature. 370:61-65.
51. Sato, H., T. Kinoshita, T. Takino, K. Nakayama, and M. Seiki. 1996. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP-2). FEBS Lett. 393:101-104.
52. Seltzer, J.L., and A.Z. Eisen. 1994. Native type 1 collagen is not a substrate for MMP2 (gelatinase A). J. Invest. Derm. 112:993.
53. Shimada, T., H. Nakamura, E. Ohuchi, Y. Fujii, Y. Murakami, H. Sato, M. Seiki, and Y. Okada. 1999. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur. J. Biochem. 262:907-914.
54. Sternlicht, M.D., A. Lochter, C.J. Sympson, B. Huey, J.-P. Rougier, J.W. Gray, D. Pinkel, M.J. Bissell, and Z. Werb. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:137-146.
55. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Clift, M.J. Bissell, and Z. Werb. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol. 125:681-693.
56. Tanney, D.C., L. Feng, A.S, Pollock, and D.H. Lovett. 1998. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev. Dyn. 213:121-129.
57. Toth, M., D.C. Gervasi, and R. Fridman. 1997. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells. Cancer Res. 57:3159-3167.
58. Ueno, H., H. Nakamura, M. Inoue, K. Imai, M. Noguchi, U. Sato, M. Seiki, and Y. Okada. 1997. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 57:2055-2060.
59. Urena, J.M., A. Merlos-Suarez, J. Baselga, and J. Arribas. 1999. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-α and membrane type matrix metalloprotease (MT1-MMP). J. Cell Sci. 112:773-784.
60. Velasco, G., S. Cal, A. Merlos-Suarez, A.A. Ferrando, S. Alvarez, A Nakano, J. Arribas, and C. Lopez-Otin. 2000. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors, Cancer Res. 60:877-882.
61. Vu, T.H., J.M. Shipley, G. Bergers, J.E. Berger, J.A. Helms, D. Hanahan, S.D. Shapiro, R.M. Senior, and Z. Werb. 1998. MMP9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-122.
62. Wang, M., X. Qin, J.S. Mudgett, T.A. Ferguson, R.M. Senior, and H.G. Welgus. 1999. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. USA. 96:6885-6889.
63. Weiss, S.J. 1989. Tissue destruction by human neutrophils. N. Engl. J. Med. 320: 365-376.
64. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:439-142.
65. Witty, J.P., J.H. Wright, and L.M. Matrisian. 1995. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell. 6:1287-1303.
66. Yana, I., and S.J. Weiss. 2000. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol. Biol. Cell. In press.
67. Yu, Q., and I. Stamenkovic. 2000. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14:163-176.